Active ingredientBosutinibCat. No. P-B101-001CAS 380843-75-4Family · Pharmaceutical analytical standards
Bosutinib
A BCR-ABL and Src tyrosine kinase inhibitor, approved in the United States in 2012 for Philadelphia chromosome-positive chronic myeloid leukaemia, initially in patients resistant or intolerant to previous therapies. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It came from a series of molecules designed to block the Src kinase (its development code was SKI-606) and turned out to be a potent inhibitor of BCR-ABL too, the protein that drives chronic myeloid leukaemia.
Go to the active ingredient →Active ingredientBosutinibCat. No. P-B101-001CAS 380843-75-4
Isotopically labelledBosutinib-d8Cat. No. P-B101-002CAS 2733145-45-2
NitrosamineN-Nitroso BosutinibCat. No. P-B101-003
NitrosamineN-Nitroso N-Desmethyl BosutinibCat. No. P-B101-004
Impurity1,2-dimethoxy-4-nitrobenzeneCat. No. P-B101-005CAS 709-09-1
Impurity1,3-Diethyl-1,3-dimethylureaCat. No. P-B101-006CAS 31468-19-6
Impurity1,3-DiisopropylureaCat. No. P-B101-007CAS 4128-37-4
Impurity2,4-Dichloro-5-methoxyanilineCat. No. P-B101-008CAS 98446-49-2
ImpurityBosutinib Impurity 1Cat. No. P-B101-009CAS 219786-51-3
ImpurityBosutinib Impurity 2Cat. No. P-B101-010CAS 92878-95-0
ImpurityBosutinib Impurity 3Cat. No. P-B101-011CAS 846023-24-3
Impurity3-(2-Methoxy-5-nitrophenoxy)propan-1-olCat. No. P-B101-012CAS 1156068-41-5
Impurity3-Allyloxy-4-methoxynitrobenzeneCat. No. P-B101-013CAS 142072-71-7
Impurity4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrileCat. No. P-B101-014CAS 214470-68-5
ImpurityBosutinib Impurity 4Cat. No. P-B101-015CAS 263149-10-6
ImpurityBosutinib Carboxylic AcidCat. No. P-B101-017
ImpurityBosutinib Didesmethyl ImpurityCat. No. P-B101-020CAS 2468737-94-0
ImpurityBosutinib Impurity 5Cat. No. P-B101-021CAS 2095306-26-4
ImpurityBosutinib Impurity 6Cat. No. P-B101-022CAS 492444-39-0
ImpurityBosutinib Impurity 7Cat. No. P-B101-024
ImpurityBosutinib Impurity 8Cat. No. P-B101-025
ImpurityBosutinib Impurity 9Cat. No. P-B101-027
ImpurityBosutinib Impurity 10Cat. No. P-B101-028
ImpurityBosutinib Impurity 11Cat. No. P-B101-029
ImpurityBosutinib Impurity 12Cat. No. P-B101-030
ImpurityBosutinib Impurity 13Cat. No. P-B101-032CAS 380844-49-5
ImpurityBosutinib Impurity 14Cat. No. P-B101-033CAS 1460227-29-5
ImpurityBosutinib Impurity 15Cat. No. P-B101-035CAS 1391063-17-4
ImpurityBosutinib Impurity 16Cat. No. P-B101-037CAS 846023-56-1
ImpurityBosutinib Impurity 17Cat. No. P-B101-043CAS 2468737-90-6
ImpurityBosutinib Impurity 18Cat. No. P-B101-045CAS 2468737-92-8
ImpurityBosutinib Impurity 19Cat. No. P-B101-046CAS 2468737-93-9
ImpurityBosutinib Oxydechlorinated ImpurityCat. No. P-B101-048
ImpurityBosutinib Piperazine N1-OxideCat. No. P-B101-049CAS 2468737-96-2
ImpurityBosutinib Propoxy Dimer ImpurityCat. No. P-B101-050CAS 2095306-27-5
ImpurityDes(4-methyl-1-piperazinyl)propyl Methyl BosutinibCat. No. P-B101-051CAS 380843-12-9
ImpurityBosutinib Impurity 20Cat. No. P-B101-052CAS 65182-98-1
ImpurityN-Desmethyl BosutinibCat. No. P-B101-053CAS 380843-81-2
ImpurityN-Ethyl-N-methylcarbamoyl chlorideCat. No. P-B101-054CAS 42252-34-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.